What’s next, after FDA’s full approval of Pfizer vaccine?

August 23, 2021

What’s next, after FDA’s full approval of Pfizer vaccine?

A COVID-19 vaccine originally authorized for emergency use in the United States reached a milestone today, with the Food and Drug Administration giving Pfizer’s vaccine its full approval for people ages 16 and older.

Pfizer’s vaccine will now be marketed under the name Comirnaty. For children ages 12-15, it continues to be available only under emergency-use authorization.

In downloadable video assets, UW Medicine general internist Dr. Joshua Liao explains how the approval could affect vaccine rates, vaccine mandates and booster shots.

Randy Carnell, UW Medicine

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington Health Sciences schools (Dentistry, Medicine, Nursing, Pharmacy, Public Health, Social Work).
  • Works must be attributed/credited appropriately (for example, “UW Medicine” or “University of Washington School of Pharmacy” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images from Thinkstock but cannot grant republishing rights. You may not republish single image files credited to Thinkstock.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or mediarelations@uw.edu